Home » Newsletters » BioWorld

BioWorld

Jan. 6, 1993

View Archived Issues

PROCYTE FILES FOR OFFERING

SCICLONE'S HEPATITIS DRUG ENTERS PHASE III

LIPOSOME TECH FILES PLA IN U.K.

EYE TREATMENT DESIGNATED ORPHAN DRUG

GENTA FILES IND FOR DERMATOLOGICAL DRUG

ECOGEN CROSS-LICENSING PACT IN AUSTRALIA

CALGENE ASKS FDA TO RULE ON GENE

DRUG APPROVALS: FEW AND FAR BETWEEN

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...